In MCL cells, BTZ innate resistance has been linked to the accumulation of the anti-apoptotic protein MCL-1 [101] and/or to the constitutive activation of the NF-κB signaling pathway [102]. Here, NFKB1 is linked to mantle cell lymphoma.